The H1 FY 2023 Ebos Group results were strong, thanks to a combination of acquired and organic growth.

The FY 2022 Ebos Group results show a decent defensive dividend stock, but ongoing capital investment will be required for growth.

I use watchlists with target desired buy prices to help me take advantage of market volatility in a calm and measured way.

The Ebos Group half year report showed decent growth, both organic and through acquisitions. But the Ebos share price is up, leading to a lower dividend yield.

The Ebos Group (ASX: EBO) retail equity offer has me considering if I want to increase my position, or arbitrage the discount for a profit.

ASX listed healthcare stock EBOS Group (ASX:EBO) reports solid earnings per share growth and has increased its dividend accordingly.

At the current share price, EBOS Group (ASX: EBO) pays a 4.5% grossed up dividend and trades on a P/E of about 20. Good value dividend stock?

Here’s it’s defensive and why there is still good upside…

Reflections on the volatility and a stream of consciousness rumination on 5 stocks I like now.

A safer place to play? Each of these 10 companies have announced that they are definitely benefitting from the imposition of social distancing…